Join Growin Stock Community!

Sol-gel technologies ltd.SLGL.US Overview

US StockHealthcare
(No presentation for SLGL)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

SLGL AI Insights

SLGL Overall Performance

SLGL AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

SLGL Recent Performance

-5.34%

Sol-gel technologies ltd.

0.05%

Avg of Sector

-0.31%

S&P500

SLGL PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

SLGL Key Information

SLGL Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

SLGL Profile

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Price of SLGL

SLGL FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

SLGL Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.23
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
13.46
PB Ratio
9.54
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
100.00%
Net Margin
-47.37%
Revenue Growth (YoY)
62.04%
Profit Growth (YoY)
62.04%
3-Year Revenue Growth
15.29%
3-Year Profit Growth
15.29%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.23
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
13.46
PB Ratio
9.54
Price-to-FCF
-
Gross Margin
100.00%
Net Margin
-47.37%
Revenue Growth (YoY)
62.04%
Profit Growth (YoY)
62.04%
3-Year Revenue Growth
15.29%
3-Year Profit Growth
15.29%

  • When is SLGL's latest earnings report released?

    The most recent financial report for Sol-gel technologies ltd. (SLGL) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating SLGL's short-term business performance and financial health. For the latest updates on SLGL's earnings releases, visit this page regularly.

  • What is the operating profit of SLGL?

    According to the latest financial report, Sol-gel technologies ltd. (SLGL) reported an Operating Profit of -6.29M with an Operating Margin of -1,572% this period, representing a decline of 659.42% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is SLGL's revenue growth?

    In the latest financial report, Sol-gel technologies ltd. (SLGL) announced revenue of 400K, with a Year-Over-Year growth rate of -92.54%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does SLGL have?

    As of the end of the reporting period, Sol-gel technologies ltd. (SLGL) had total debt of 1.08M, with a debt ratio of 0.03. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does SLGL have?

    At the end of the period, Sol-gel technologies ltd. (SLGL) held Total Cash and Cash Equivalents of 6.72M, accounting for 0.19 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does SLGL go with three margins increasing?

    In the latest report, Sol-gel technologies ltd. (SLGL) did not achieve the “three margins increasing” benchmark, with a gross margin of 100%%, operating margin of -1,572%%, and net margin of -1,485.5%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess SLGL's profit trajectory and future growth potential.

  • Is SLGL's EPS continuing to grow?

    According to the past four quarterly reports, Sol-gel technologies ltd. (SLGL)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -2.13. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.